One of our most significant achievements has been the Lung Cancer Research Program within the Congressional Directed Medical Research Program administered by the Department of Defense (DOD).
The Lung Cancer Research Program now has a total of $155.5 million in funding over the past ten years (FY09-FY20), making it the largest lung cancer research program – public or private – outside of the National Cancer Institute (NCI) at the National Institute of Health (NIH). Research topics include biomarkers of disease recurrence, cutting edge immunotherapies, targeted tests and treatments with added emphasis on under-researched small cell lung cancer.
First secured by Lung Cancer Alliance in 2008, annual appropriations by Congress are required to maintain the program, a process that has been successfully shepherded each year through our network of support on Capitol Hill.
Want to learn more about the Lung Cancer Research Program and the need for lung cancer research funding? Explore these resources:
- Visit the Lung Cancer Research Program website for more information on the program and lung cancer grants.
- View the most recent official Lung Cancer Research Program brochure issued by DOD.
- Watch the Lung Cancer Living Room: “The Path to Lung Cancer Research Funding” episode to learn about GO2 for Lung Cancer’s history in securing federal funds and partnering with Congress, the CDMRP (Congressionally Directed Medical Research Programs through the Department of Defense) and the role of patient advocates.
- Download the fact sheets below to raise awareness about the need for increased lung cancer research funding.
.